Pharmacy
Despite the disappointing results, Pfizer maintains the drug remains effective at preventing severe instances of the disease.
HHS is supporting the continued research and development of the company's COVID-19 vaccine development efforts with federal funding.
The trend is expected to continue this year, with drug spending poised to grow 4 to 6%, driven by increases in utilization, prices and new drugs.
Protection against infection only lasts about a month, but protection against severe reaction to the virus lasts far longer.
Both Eliquis and Xarelto carry a price of more than $200 for a month's supply, a far cry from the $10 price tag for warfarin.
The service will be known as AllianceRx Walgreens Pharmacy to reflect the company's full ownership of the prescription delivery platform.
CVS Pharmacy will no longer be a defendant in the Florida opioid lawsuit, scheduled for trial in April.
Pfizer is also able to give a second booster dose to individuals 12 and older who are immunocompromised.
Several measures propose capping monthly out-of-pocket costs for insulin at $35, an issue that Biden mentioned during his State of the Union address.
Positive results from a Phase 2/3 study suggest the vaccine is safe and effective in younger populations, with few adverse events reported.